Write to us

Please explain why this publication should not be displayed on our website.
Ok, message sent.
Message not sent.

Categories

Regions

Korea United Pharm Int’l JSC

Contact us

Contact

KUP is a technology & innovation oriented company. In 2004, KUP carried out a variety of national products by being selected as an Advanced Technology Center by the MOTIE(Ministry of Commerce, Industry and Energy) and in 2012, was selected as “Innovative Pharmaceutical Company” by Korean government and in 2014, was selected “World Class 300 project”. The company is consistently being recognized for its technology & innovation.

As a result of R&D investment of more than 10% annually, the company has developed IMD(Incrementally Modified Drug) products; Clanza CR Tab(in 2010), Clavixin-duo Cap(in 2012) and Cilostan CR Tab(in 2013). In 2013, KUP was ranked in the highest level among the domestic pharmaceutical companies for the R&D investment ratio, marking 12.4% of its sales. Currently, the company holds 72 patents in domestic and 8 patents in overseas. The R&D team has been operated actively by highly qualified 90 experts. They are continuously striving to develop the innovative products for a healthier life of people all around the world.

  • Company: Korea United Pharm Int’l JSC (KUP)
  • Tax Number: 3700372898
  • Registration Date: 21/05/2001
  • Address: 2A Dai Lo Tu Do Boulvard, Vietnam – Singapore (VSIP), Thuan An District, Binh Duong, Vietnam
  • Phone: +84 274 378 2980
  • Fax: +84 274 378 2981
  • Email: [email protected] / [email protected]
  • Website: kup.co.kr / vietnampharm.com

Products: IMD (Incrementally Modified Drug), Anti-cancer, Prescription, OTC

Location

2A Dai Lo Tu Do Boulvard, Vietnam - Singapore (VSIP), Thuan An District, Binh Duong, Vietnam